Ключевые слова
antihypertensive agent; adrenergic system; blood pressure; clinical trial (topic); cost of illness; drug combination; drug effect; drug monitoring; drug potentiation; economics; human; hypertension; pathophysiology; patient compliance; renin angiotensin aldosterone system; review; treatment outcome; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Cost of Illness; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Humans; Hypertension; Patient Compliance; Renin-Angiotensin System; Treatment Outcome; Vasomotor System